Skip to main content
. 2020 Nov 6;4:PO.20.00122. doi: 10.1200/PO.20.00122

FIG 3.

FIG 3.

Clinical outcome after infusion of first-line chemotherapy. Kaplan-Meier curves for (A) progression-free survival (PFS) of patients with homologous recombination pathway alterations compared with those with wild type (WT). (B) PFS of patients with homologous recombination pathway alterations compared with those with WT stratified by BRCA status. (C) Overall survival (OS) of patients with homologous recombination pathway alterations compared with those with WT. (D) OS of patients with homologous recombination pathway alterations compared with those with WT stratified by BRCA status. HR, hazard ratio.